Evidence map›Paper›PMID 30886146›Full record

ArticleNature communications2019

UFL1 promotes histone H4 ufmylation and ATM activation.

Bo Qin, Jia Yu, Somaira Nowsheen, Minghui Wang, Xinyi Tu, Tongzheng Liu, Honglin Li, Liewei Wang, Zhenkun Lou

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 114 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
114citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

114 citing papers in PubMed, 1 synthesis or guideline pooled it, 179 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. The mechanistic basis and cellular functions of UFMylation.Nature reviews. Molecular cell biology · 2026
    Review
  8. Article
  9. Article
  10. UFMylation of Pyruvate Dehydrogenase Regulates Mitochondrial Metabolism.bioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

54 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Bo QinDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Jia YuDivision of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0001-8342-5423
Somaira NowsheenDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0001-7174-5366
Minghui WangDepartment of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, 1470 Madison Avenue, New York, NY, 10029, USA.ORCID http://orcid.org/0000-0001-9171-4962
Xinyi TuDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Tongzheng LiuInstitute of Tumor Pharmacology, Jinan University, 510632, Guangzhou, China.
Honglin LiDepartment of Biochemistry & Molecular Biology, Cancer Center, Georgia Regents University, Augusta, GA, 30912, USA.
Liewei WangDivision of Clinical Pharmacology, Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN, 55905, USA.
Zhenkun LouDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA. lou.zhenkun@mayo.edu.ORCID http://orcid.org/0000-0003-1938-3091
Mayo Clinic · USMayo Clinic in Arizona · USAugusta University · USIcahn School of Medicine at Mount Sinai · USJinan University · CN

Funding

Medical Scientist Traning Program at Mayo ClinicT32GM065841 · NIGMS · MAYO CLINIC ROCHESTER · PI KAUFMANN, SCOTT H, SCHIMMENTI, LISA A · 2003 to 2022
$5.8M
Ubiquitination and the DNA Damage Response PathwayR01CA130996 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2008 to 2018
$3.3M
Regulation of homologous recombination and cancer cell response to chemoradiotherapyR01CA203561 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2016 to 2020
$1.8M
UFM1 signaling in DNA damage response and cancer therapyR01CA217183 · NCI · MAYO CLINIC ROCHESTER · PI LOU, ZHENKUN · 2018 to 2022
$1.8M
Essential role of the Ufm1 E3 ligase in intestinal homeostasisR01DK113409 · NIDDK · AUGUSTA UNIVERSITY · PI LI, HONGLIN · 2017 to 2020
$1.4M
NCI NIH HHS R01 CA130996NCI NIH HHS R01 CA203561NCI NIH HHS R01 CA217183NIDDK NIH HHS R01 DK113409NIGMS NIH HHS T32 GM065841NIH HHS CA130996NIH HHS CA203561NIH HHS CA217183
6 · The paper itself

Abstract

The ataxia-telangiectasia mutated (ATM) kinase, an upstream kinase of the DNA damage response (DDR), is rapidly activated following DNA damage, and phosphorylates its downstream targets to launch DDR signaling. However, the mechanism of ATM activation is still not completely understood. Here we report that UFM1 specific ligase 1 (UFL1), an ufmylation E3 ligase, is important for ATM activation. UFL1 is recruited to double strand breaks by the MRE11/RAD50/NBS1 complex, and monoufmylates histone H4 following DNA damage. Monoufmylated histone H4 is important for Suv39h1 and Tip60 recruitment. Furthermore, ATM phosphorylates UFL1 at serine 462, enhancing UFL1 E3 ligase activity and promoting ATM activation in a positive feedback loop. These findings reveal that ufmylation of histone H4 by UFL1 is an important step for amplification of ATM activation and maintenance of genomic integrity.

Indexed as

DNA RepairAcid Anhydride HydrolasesAtaxia Telangiectasia Mutated ProteinsCell Cycle ProteinsCell Line, TumorDNA-Binding ProteinsDNA Breaks, Double-StrandedDNA Repair EnzymesHEK293 CellsHistonesHumansLysine Acetyltransferase 5MethyltransferasesMRE11 Homologue ProteinNuclear ProteinsPhosphorylationAcid Anhydride HydrolasesAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsDNA-Binding ProteinsDNA Repair EnzymesHistonesKAT5 protein, humanLysine Acetyltransferase 5MethyltransferasesMRE11 Homologue ProteinMRE11 protein, humanNBN protein, humanNuclear ProteinsRAD50 protein, humanRepressor ProteinsRNA, Small InterferingSerineSUV39H1 protein, humanUbiquitin-Protein LigasesUFL1 protein, human

Identifiers

PMID30886146
PMCPMC6423285
OpenAlexW2921490676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.